Capricor Therapeutics is trading 12.15% up at $9.60, moving alongside a broad September 17, 2026 risk-on rally.
- Major U.S. indexes are higher, while biotech is also gaining, supporting risk appetite across growth-oriented healthcare stocks.
- No new company-specific announcement was found for September 17.
- Recent investor-alert and class-action coverage remains ongoing, with a September 28 deadline, but does not represent a fresh catalyst for today’s move.